Key result
Non-bacterial thrombotic endocarditis causes ischemic stroke in cancer, highlighting the need for TEE.
Why the study?
Ischemic stroke in oncological diseases is caused by cancer-related prothrombotic effects and antitumor therapy, with non-bacterial thrombotic endocarditis as a common cause of cerebral embolism.
Case Report (n=1)
May prompt TEE evaluation in cancer-associated stroke; leaves open whether NBTE-focused strategies improve outcomes.
Ischemic stroke in oncological diseases occurs as a result of the prothrombotic effect caused by cancer. Besides that, it is associated with antitumor therapy. In the first instance, cardioembolism should be ruled out for recurrent systemic embolism in patients with a tumor history. In most cases, the cause of cerebral embolism in oncological diseases is non-bacterial thrombotic endocarditis. Its diagnosis preferably based on transesophageal echocardiography. This article presents a clinical case of ischemic stroke developed by marantic endocarditis, methods of its verification and treatment.
No takes yet. Share an insight, caveat, or question.
Ramazanov et al. (2022) conducted a case report in Ischemic stroke associated with non-bacterial thrombotic endocarditis and oncological disease (n=1). Diagnosis and treatment of marantic endocarditis was evaluated. A clinical case highlights that non-bacterial thrombotic (marantic) endocarditis, verified preferably by transesophageal echocardiography, is a key cause of ischemic stroke in cancer patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: